Protons 101

Home
Notes
Archive
About
Most Popular
View all
If Radiation Were a Drug...
 • Mark Storey MD
2
IMRT is the de facto standard of care for the treatment of definitive disease
 • Mark Storey MD
A Glimpse Behind the Curtain: ViewRay
 • Mark Storey MD
5
The Opportunity in High Risk Prostate Cancer: De-escalation of ADT.
 • Mark Storey MD
11
Massive Benefit using Radiation in Metastatic Disease!!
 • Mark Storey MD
2
Sunset Trial: Pushing Dose in Lung Cancer
 • Mark Storey MD
Translating New RBE Modeling to the Clinic
A Concept...
 • 
Mark Storey MD
5
IMRT is the de facto standard of care for the treatment of definitive disease
Prior authorization denials for IMRT in definitive cancer treatment cases should be an embarrassment to everyone in cancer care.
 • 
Mark Storey MD
Proton Therapy for Lung Cancer
In a search for better...
 • 
Mark Storey MD
The Opportunity in High Risk Prostate Cancer: De-escalation of ADT.
Our data is old creating opportunity.
 • 
Mark Storey MD
11
Market trends: A Rebuttal
A recent article made my blood boil. We'll look deeper and see if my gut was right or wrong.
 • 
Mark Storey MD
2
Sunset Trial: Pushing Dose in Lung Cancer
How quickly and high can we go in Ultra-Central Disease?
 • 
Mark Storey MD
2023: A look back
"Just write" for one year...
 • 
Mark Storey MD
4
Protons 101
Protons 101
A Substack dedicated to Radiation Oncology with an emphasis on technology, business, and the tremendous value we represent in the field of oncology. Technical content in a less formal setting. All the cool kids are here - join us!

Protons 101

AboutArchiveSitemap
© 2024 Mark Storey MD
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great culture